Wall Street Is Betting That SNDL Stock Can More Than Double in the Next Year. Should You Buy Shares Here?
shares gained nearly 12% on Wednesday. Dec. 16 following reports that President Donald Trump could reclassify cannabis as a Schedule III drug by the end of this week.The U.S. government is considerin…